Targeted next-generation sequencing for pediatric lower respiratory tract infections: a retrospective study
Frontiers in Cellular and Infection Microbiology · 28.08.2025 · 15
DOI: 10.3389/fcimb.2025.1652949 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 28.08.2025. Verfasst von Linlin Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Medical Science Laboratory, Children's Hospital, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, China. Hauptthemen laut MEDLINE: High-Throughput Nucleotide Sequencing, Respiratory Tract Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
Lower respiratory tract infections (LRTIs), including bronchitis and pneumonia, are common pediatric conditions. Accurate and timely pathogen identification is essential in this population, with targeted next-generation sequencing (tNGS) significantly improving detection rates. This study aimed to systematically assess the clinical utility of tNGS in identifying pathogens in pediatric LRTIs.
Methods
A retrospective analysis of 107 pediatric patients with lower respiratory tract infections (LRTIs) was conducted between January 2024 and December 2024. The concordance of tNGS, quantitative polymerase chain reaction (qPCR), and microbial culture results with clinical diagnoses was assessed. Data were analyzed using the Statistical Package for the Social Sciences (SPSS), with statistical significance set at P < 0.05.
Results
Of the 107 pediatric patients, 34 (31.8%) had single-pathogen infections while 73 (68.2%) had multiple infections, with bacterial-viral co-infections comprising 42.5% of the latter group. The tNGS results demonstrated a concordance rate of over 66% with clinical diagnoses, which was significantly higher (P < 0.001) than that of qPCR and culture. The analysis revealed 80% concordance between tNGS and qPCR results. Notably, tNGS demonstrated 90% concordance with culture methods in approximately 70% of comparative detections. Furthermore, for Human rhinovirus and Mycoplasma pneumoniae , the RPM values for tNGS were significantly higher (P<0.05) in (tNGS+qPCR+) samples than in (tNGS+qPCR−) samples. Compared with Human rhinovirus (AUC=0.759), Mycoplasma pneumonia e exhibited stronger discriminatory power (AUC=0.917).
Conclusion
The tNGS results demonstrated high concordance with the clinical diagnosis, supporting its high applicability in diagnosing pathogens in pediatric patients with severe, mixed, or refractory infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Science Laboratory, Children's Hospital, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
- Department of Pediatric Respiratory Medicine, Children's Hospital, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Zitieren
APA
Li, L., Guo, J., Chen, J., Zhao, J., Liang, J., & Liu, M. (2025). Targeted next-generation sequencing for pediatric lower respiratory tract infections: a retrospective study. Frontiers in Cellular and Infection Microbiology, 15. https://doi.org/10.3389/fcimb.2025.1652949
Vancouver
Li L, Guo J, Chen J, Zhao J, Liang J, Liu M. Targeted next-generation sequencing for pediatric lower respiratory tract infections: a retrospective study. Frontiers in Cellular and Infection Microbiology. 2025;15. doi:10.3389/fcimb.2025.1652949
BibTeX
@article{Li2025,
author = {Li, Linlin and Guo, Jing and Chen, Jielin and Zhao, Jiangyang and Liang, Jiahui and Liu, Minxue},
title = {Targeted next-generation sequencing for pediatric lower respiratory tract infections: a retrospective study},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
volume = {15},
doi = {10.3389/fcimb.2025.1652949}
}
EUVIMED